Welcome to the CEO Roundtable on Cancer

Gold Standard Advancing to Reflect Latest Oncology Research

Oncology is perhaps the world’s fastest-moving therapeutic area. That requires the CEO Cancer Gold Standard™ framework -- a roadmap for building healthier communities at work and play -- to change with the science too. The Gold Standard requirements have been updated over the past year to reflect a more holistic approach to health and well-being with increased emphasis on cancer survivorship, well-being, and health equity.

Learn more
CEO ROUNDTABLE ON CANCER LAUNCHES “GOING FOR GOLD” INITIATIVE TO ADVANCE EQUITABLE CANCER CARE

The non-profit CEO Roundtable on Cancer has launched a multi-year initiative – Going for Gold – in partnership with Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions (HSIs), global health care companies Amgen and Merck (known as MSD outside the United States and Canada), along with analytics leader SAS.

With a focus on improving health equity, education, navigation, and access, the program has the capacity to impact more than 20 million lives within 7-10 years, especially among communities disproportionately affected by cancer.

Learn More
Symposium X: Patients can change data-sharing landscape

There is a vast amount of underutilized clinical trial data in medical research. Speakers at a symposium sponsored by the U.S. Food and Drug Administration and the non-profit Project Data Sphere® focused on why accessing this resource is so challenging and how obstacles can be overcome.

More than 180 attendees representing Industry, Government, Non-Profits, and Academic Institutions along with members from healthcare providers, analytics companies, and patients, made it clear that clinical trial data sharing is a topic of interest.

Learn more
External Control Arm work published, featured at SNO Meeting

Work by Project Data Sphere’s (PDS) External Control Arm (ECA) program was the focus of a paper in The Lancet Oncology, published in October, and a panel discussion at the Society for Neuro-Oncology (SNO) Annual Meeting in November in Boston. Authors of “Leveraging external data in the design and analysis of clinical trials in neuro-oncology” include PDS President Bill Louv and PDS Executive Director Jon McDunn as well as leaders of the ECA Task Force established by PDS.

Learn more

Our Mission

The mission of the CEO Roundtable on Cancer is to make continual progress toward the elimination of cancer as a personal disease and public health problem through initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to treatment, and hasten the discovery of effective therapies.

Workplace Wellness

A workplace wellness accreditation program designed to encourage healthy behaviors and improve health outcomes for employees by promoting prevention measures, encouraging early detection through cancer screenings, and ensuring access to quality care.

Research Innovation

Life sciences initiatives that bring together oncology, biotechnology and pharmaceutical companies to collaborate on removing obstacles and finding new ways to accelerate discovery and development of new therapies for cancer patients.

Global Cancer Control

Programs that catalyze progress in employee health at a global level and provide an environment that enables the compilation of historical oncology clinical trial data that will open new avenues of research.

Webinars to fuel discussion in 2022

A series of 45- to 60-minute webinars are planned for 2022 to continue the discussions started at the Annual Conference in 2021. The series will begin in January and includes the following topics:

Glioblastoma: Innovative Data Re-Use to Accelerate Evidence Generation for New Medicines: This virtual panel will focus on recent efforts in glioblastoma research to apply external controls in adaptive clinical trials and to help interpret results from early phase cell therapy trials.

Learn more

JANUARY IS CERVICAL HEALTH AWARENESS MONTH

More than 14,000 women in the United States are diagnosed with cervical cancer each year although the disease is preventable with vaccination and appropriate screening. Cervical cancer is nearly always caused by infection with the human papillomavirus (HPV), reports the National Cancer Institute. The Centers for Disease Control recommend getting the HPV vaccine early and having regular screenings (Pap test and HPV test) as the most important things to help prevent cervical cancer. Both are supported by our Cancer Gold Standard.

Learn more here: https://www.cdc.gov/cancer/cervical/index.htm and https://www.cancer.gov/types/cervical.